Blueprint Medicines Corporation
Blueprint Medicines Corporation (BPMC) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
bpmc · stock forecast · 34 analysts (3M) · FMP · updated Aug 18, 2025
Analyst Rating & Consensus
Based on 34 Wall Street analysts in the past 3 months
Buy
34 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$155
Consensus
$113
-12.7% upside
Low
$41.00
Median: $120 · Last Close: $129.46
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$113.07
-12.7% upside
High Target
$155
19.7%
Low Target
$41
-68.3%
Current Price
$129.46
as of today
Based on analyst price targets, the BPMC stock price prediction for the next 12 months ranges from $41 to $155. The consensus BPMC price forecast of $113.07 implies -12.7% upside from the current price of $129.46.
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $129.65 | ↑ 0.15% |
1-day model range: $129.6–$129.7. Peak: $129.7 (+0.15%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $126 | -3.1% |
| 2028 | $123 | -4.8% |
| 2029 | $122 | -5.9% |
| 2030 | $121 | -6.5% |
| 2031 | — | -6.9% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · BPMC · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-06-17 | Wells Fargo | Downgrade ↓ | Overweight→Equal Weight |
| 2025-06-05 | UBS | Maintains | Neutral→Neutral |
| 2025-06-05 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2025-06-04 | Citigroup | Upgrade ↑ | Sell→Neutral |
| 2025-06-03 | JMP Securities | Downgrade ↓ | Market Outperform→Market Perform |
| 2025-06-03 | Wolfe Research | Downgrade ↓ | Outperform→Peer Perform |
| 2025-06-02 | Scotiabank | Downgrade ↓ | Sector Outperform→Sector Perform |
| 2025-06-02 | Wedbush | Downgrade ↓ | Outperform→Neutral |
| 2025-06-02 | JP Morgan | Downgrade ↓ | Overweight→Neutral |
| 2025-06-02 | Needham | Downgrade ↓ | Buy→Hold |
Wall Street analysts have recently issued updated ratings on Blueprint Medicines Corporation (BPMC) stock. Of the recent 208 rating actions, 12 were upgrades and 14 were downgrades. 34 analysts currently cover BPMC.
Analyst Recommendation Trends
BPMC analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$721M
↓ 38.6% YoY
Revenue Next Year
$954M
↑ 32.2% YoY
EPS This Year
$-0.70
EPS Next Year
$0.92
↓ 231.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast BPMC EPS of $-0.70 for the current fiscal year, based on estimates from 12 analysts. The BPMC revenue forecast is $721M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The BPMC stock forecast is supported by two independent data sources: analyst consensus ratings from 34 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BPMC price target is $113.07 (-12.7% upside), with an analyst consensus of Buy.
The BPMC short-term stock prediction for tomorrow is $129.65 (+0.15%). The BPMC stock price prediction for 2027 estimates an average of $126. The BPMC stock prediction for 2030 projects a range of $121–$121.
Blueprint Medicines Corporation trades on NASDAQ under the ticker BPMC. The BPMC stock outlook for 2027 is broadly positive, supported by a Buy consensus among 53% of covering analysts.
Frequently asked questions
BPMC forecast · 8 questionsAccording to 34 Wall Street analysts, the average 12-month BPMC price target is $113.07, with a high forecast of $155.00 and a low of $41.00. The median price target is shown in the chart above when available. This implies -12.7% potential upside from the current price of $129.46.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.